What Happened?
Bethesda, MD-based ValenzaBio Appointed Patrick Crutcher as President, Executive Chairman, Co-Founder
About the Company
ValenzaBio is a privately-held biopharmaceutical company developing therapies for autoimmune and inflammatory diseases. With a pipeline of differentiated monoclonal antibodies targeting clinically-validated mechanisms of action, we seek to provide improved therapies for patients with limited treatment options. Based in Bethesda, Maryland, in the heart of the capital biotech community, we strive to work collaboratively with all stakeholders while keeping our research and development efforts focused on the needs of patients.
About the Person
Patrick Crutcher is President, Executive Chairman, Co-Founder at ValenzaBio. Previously, Patrick held various senior HR leadership roles in the industry.
Info Source
News
Short Profile